Teleflex Inc (TFX) reports a 2.8% revenue increase and a 15.1% rise in adjusted EPS, while announcing a strategic acquisition and share repurchase program to drive future growth.

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Teleflex experienced a dramatic 20% stock plunge on Thursday, hitting a new 52-week low of $136.60. Despite slightly exceeding analyst expectations with an adjusted earnings per share of $3.89, the ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

Citizens JMP downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The company this morning reported Q4 results ...